Intrinsic Value of S&P & Nasdaq Contact Us

Athira Pharma, Inc. ATHA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+166.7%

Athira Pharma, Inc. (ATHA) has 20 known insider and institutional holders on record. The largest holder is PERCEPTIVE ADVISORS LLC with 4,829,412 shares. Other notable holders include KAWAS LEEN and Litton Mark James.

Over the last 12 months, insiders have made 7 transactions in ATHA stock — 7 buys (valued at $45.72K) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

ATHA Insider Ownership

Top Holder
PERCEPTIVE ADVISORS LLC
4,829,412 shares
Buys (12 mo)
7
$45.72K value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 100%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Perceptive Advisors Llc 10 Percent Owner 4,829,412 2023-12-29
100%
2 Kawas Leen President & CEO 231,000 2021-02-22
5%
3 Litton Mark James President and CEO 222,543 2025-03-04
5%
4 Mileson Glenna Chief Financial Officer 150,000 2023-01-23
3%
5 Gengos Andrew CFO and Chief Business Officer 93,804 2024-09-05
2%
6 Moebius Hans Chief Medical Officer 91,482 2024-01-08
2%
7 San Martin Javier Chief Medical Officer 74,180 2025-03-04
2%
8 Church Kevin Chief Scientific Officer 58,563 2025-03-04
1%
9 Worthington Mark General Counsel and Cco 57,263 2025-03-04
1%
10 Renninger Robert SVP, Finance and Accounting 39,000 2025-03-04
1%
11 Lenington Rachel COO and Cdo 23,395 2024-09-05
0%
12 Romano Kelly A Director 20,900 2025-06-03
0%
13 Fluke John M Jr Director 20,900 2025-06-03
0%
14 Johnson James A Director 20,900 2025-06-03
0%
15 Edelman Joseph Director 20,900 2025-06-03
0%
16 Kosacz Barbara Director 20,900 2025-06-03
0%
17 Pickering Grant Director 20,900 2025-06-03
0%
18 Panzara Michael A. Director 20,900 2025-06-03
0%
19 Perceptive Life Sciences Master Fund Ltd Director 13,871 2022-05-27
0%
20 Yamada Tadataka Director 13,871 2021-06-01
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2025-05-30 Kosacz Barbara Director RSU Award 20,900 $0.31 $6.53K
2025-05-30 Romano Kelly A Director RSU Award 20,900 $0.31 $6.53K
2025-05-30 Panzara Michael A. Director RSU Award 20,900 $0.31 $6.53K
2025-05-30 Pickering Grant Director RSU Award 20,900 $0.31 $6.53K
2025-05-30 Johnson James A Director RSU Award 20,900 $0.31 $6.53K
2025-05-30 Fluke John M Jr Director RSU Award 20,900 $0.31 $6.53K
2025-05-30 Edelman Joseph Director RSU Award 20,900 $0.31 $6.53K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message